Biden’s Plans to Reduce Cost of Medicare Drugs To Send Ripple Effects Through Nursing Home Industry
By Amy Stulick
Skilled Nursing News
Following the Biden Administration’s bid this week to reduce the price of certain drugs – many of which are commonly used in nursing homes – experts are cautioning that the changes may negatively impact the bottomline of organizations in the sector.
As Medicare Part D price negotiations for these drugs come into focus this week, the Senior Care Pharmacy Coalition (SCPC), for one, is warning that changes to Part D might cause “collateral damage” to long-term care pharmacies, the patients they serve and operator partners.
On Tuesday, federal policy makers released the names of the first 10 drugs approved to be part of Medicare’s first-ever price negotiations in order to further the goals of the Inflation Reduction Act.
Certain blood thinners, diabetes treatments and medications used for COPD, cancer, heart failure, cardiovascular disease and psoriatic arthritis covered under Medicare Part D will be under price negotiations starting on Jan. 1, 2026.
Such drugs have a high expenditure, and are single source drugs without generic or biosimilar competition. Many have been on the U.S. market for an average of 13 years, according to ATI Advisory.
“Long-term care patients and pharmacies will be severely and disproportionately impacted by these price negotiations, given that eight of the medications named by the Biden administration are heavily prescribed to patients in long-term care facilities,” Alan Rosenbloom, president and CEO of SCPC, said in a statement.
Read the full original article here.
Recent Posts
-
LTC pharmacies demand ‘sustainable’ payment model ahead of 2026 drug-pricing changes
Many of the nation’s long-term care pharmacies are going to fall below “break-even” and may be forced out of business without additional support when drug-pricing policy changes kick in, sector advocates warned Wednesday.
-
Senior Care Pharmacy Coalition Launches “Save Senior Rx Care” to Protect Senior Access to Life-Saving Medications and Services
Led by the Senior Care Pharmacy Coalition (SCPC), America’s long-term care (LTC) pharmacies are launching Save Senior Rx Care, a new campaign urging Congress to protect access to life-saving medications and services for the millions of Americans who need long-term care.
-
New Report Underscores Unique Role LTC Pharmacies Play in Serving Complex Needs of Medicare Beneficiaries in Long-Term Care
A new report from the Senior Care Pharmacy Coalition (SCPC), the nation’s leading voice for long-term care (LTC) pharmacies, and ATI Advisory (ATI) highlights the clinical and functional complexity faced by millions of Medicare beneficiaries residing in nursing facilities and assisted living.
Stay in the Know
Get the latest news and updates on issues impacting the long-term pharmacy community.